In HHC, NNT-AS1 can sponge miR-363, reducing the targeted inhibition of cyclin-dependent kinase 6 (CDK6) by miR-363, thereby increasing the expression of CDK6 and promoting proliferation of cancer cells [21]. Here, CDK6 is linked to cancer.